Fenbendaz\u00f2l (yon medikaman yo itilize pou dev\u00e8mi chen), geri yon pasyan ki gen kans\u00e8 nan poumon ki gen ti selil.<\/p>\n\n
Ni FDA ni EMA ent\u00e8di itilizasyon fenbendaz\u00f2l lakay moun ak\u00f2z toksisite potansy\u00e8l ak ef\u00e8 teratogenik. D\u00f2z rek\u00f2mande pou b\u00e8t yo siyifikativman pi wo pase konsomasyon chak jou akseptab pou moun, sa ki soulve enkyetid kons\u00e8nan sekirite l\u00e8 pasyan kans\u00e8 yo administre l poukont yo. <\/p>\n\n
Kounye a, pa gen okenn pr\u00e8v epidemyolojik solid ki sip\u00f2te itilizasyon fenbendaz\u00f2l k\u00f2m yon tretman kans\u00e8 efikas lakay moun. Afimasyon yo baze prensipalman sou rap\u00f2 anekdotik olye ke etid klinik byen dokimante. <\/p>\n\n
Etid yo montre ke fenbendaz\u00f2l ka anpeche kwasans selil kans\u00e8 yo in vitro (nan laboratwa a) l\u00e8 li destabilize mikrotubil yo, ki enp\u00f2tan pou divizyon selil\u00e8. Pa egzanp, li te montre toksisite pou selil tim\u00e8 mam\u00e8 sourit EMT6 yo epi yo te sijere li gen pwopriyete antikanser\u00e8z atrav\u00e8 destabilizasyon mikrotubil yo. Sepandan, rezilta sa yo limite a kilti selil\u00e8 ak mod\u00e8l b\u00e8t, san okenn pr\u00e8v konklizyon nan es\u00e8 klinik imen. <\/p>\n\n
Nan etid sou b\u00e8t, tankou sa yo ki te f\u00e8t sou tim\u00e8 mam\u00e8 sourit EMT6 yo, fenbendaz\u00f2l pa t chanje kwasans tim\u00e8 a yon fason siyifikatif ni amelyore ef\u00e8 radyoterapi a. Gen k\u00e8k etid sou sourit ki te montre yon rediksyon nan kwasans tim\u00e8 a l\u00e8 yo te itilize fenbendaz\u00f2l an konbinezon ak l\u00f2t tretman, men rezilta sa yo pa t repwodui nan moun. <\/p>\n\n
pa klase.<\/p>\n\n
Si w ap konsidere tretman alt\u00e8natif pou kans\u00e8, li enp\u00f2tan anpil pou w konsilte ak founis\u00e8 swen sante w la. Konte sou tretman ki pa pwouve ka mennen nan ef\u00e8 negatif sou sante epi retade itilizasyon terapi etabli ak efikas. Rete sou tretman ki baze sou pr\u00e8v epi diskite sou nenp\u00f2t terapi konplemant\u00e8 ak dokt\u00e8 w la. <\/p>\n\n
Malgre ke etid laboratwa yo sijere ke fenbendaz\u00f2l gen pwopriyete potansy\u00e8l kont kans\u00e8, pa gen okenn pr\u00e8v konklizyon ki montre ke li efikas oswa san danje pou trete kans\u00e8 nan moun. Afimasyon sou kapasite li pou geri kans\u00e8 yo pa sip\u00f2te pa done syantifik solid, epi oto-administrasyon poze risk sante enp\u00f2tan. Toujou ch\u00e8che kons\u00e8y medikal pwofesyon\u00e8l anvan ou konsidere tretman alt\u00e8natif. <\/p>\n","protected":false},"excerpt":{"rendered":"
Sa ou ka tande Fenbendaz\u00f2l (yon medikaman yo itilize pou dev\u00e8mi chen), geri yon pasyan ki gen kans\u00e8 nan poumon ki gen ti selil. Sa syans lan di nou Ni FDA ni EMA ent\u00e8di itilizasyon fenbendaz\u00f2l lakay moun ak\u00f2z toksisite potansy\u00e8l ak ef\u00e8 teratogenik. D\u00f2z rek\u00f2mande pou b\u00e8t yo siyifikativman pi wo pase konsomasyon chak…<\/p>\n","protected":false},"author":9,"featured_media":8301,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[522],"tags":[539],"class_list":["post-8299","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pwoblem-medikal-oswa-tretman","tag-enpak-sou-risk-kanse-a-poko-detemine"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=8299"}],"version-history":[{"count":5,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8299\/revisions"}],"predecessor-version":[{"id":18148,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8299\/revisions\/18148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/8301"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=8299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=8299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=8299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}